Long‑term experience in patients undergoing endovascular revascularization procedures for symptomatic Takayasu arteritis (RCD code: I-3A.1)

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2013, Vol 1, Issue 5

Abstract

Takayasu arteritis (TA) is often manifested by a prolonged limb claudication, renovascular hypertension or a sudden ischemic stroke (IS) or myocardial infarction (MI) occurring in young adults. The study aimed to assess the long‑term outcome in patients with TA referred to endovascular revascularization procedure (PTA). Methods. The study group comprised 20 patients with TA (19 women, 1 men), at the mean age of 45.3±6.6 (range 30–52) years at the time of the first diagnosis of an arterial stenosis. In 70% of patients significant stenosis or occlusion affected more than one major arterial territory. Significant coronary stenosis was observed in 8(40%) patients. All patients were assessed for the prevalence of cardiovascular risk factors, inflammatory activity (hs‑CRP, white blood count: – WBC) and the incidences of restenosis (RS), cardiovascular death (CVD), MI, IS/TIA or symptomatic lesion progression at follow‑up (SLP). Results. A total of 28 PTAs were performed as a result of the initial evaluation, including 11 subclavian or innominate, 6 carotid, 8 renal, 1 vertebral, 1 coronary and 1 PTA of the abdominal aorta. During the follow‑up period of 98 ±28 months (range 12–165 months), CV events occurred in 3(15%) patients, including 1(5%) CVD, 1(5%) IS, and 1(5%) IM. SLP was observed in 11(55%) patients in 17 previously non obstructed arterial locations. 14 of these lesions required PTA. Significant RS in at least one revascularized artery concerned 11(55%) patients and was observed in case of 13 previously performed PTA’s; 11 of those lesions required re‑PTA. Recurrent RS was noted in 4 patients. Conclusions. In patients with TA, RS and SLP rates are high, thus the follow‑up of these patients is crucial. PTA is a valuable alternative to surgery for patients with TA. JRCD 2013; 1 (5): 8–13

Authors and Affiliations

Leszek Wrotniak, Anna kabłak-Ziembicka, Tadeusz Przewłocki, Piotr Pieniążek, Jakub Podolec, Krzysztof Żmudka

Keywords

Related Articles

JRCD is now included in the J‐Gate database, Free Medical Journals list, and JournalTOCs

We present to you the first issue of Journal of Rare Cardiovascular Diseases (JRCD) for 2018.

Prognostic value of inflammatory markers in acute coronary syndrome in a population with premature cardiovascular disease

Introduction: Inflammation plays a significant role in the development of atherosclerosis, and inflammatory markers could be used in risk assessment of patients with ischaemic heart disease. The use of such markers could...

Long QT syndrome diagnosed in the postpartum period (RCD code: VII-V-1A.2)

We report a case of 22 years old woman with long QT syndrome type with the first cardiac incidents in the post partum period. We discuss the actual treatment recommendation in the long QT syndrome with special attention...

Development of the European Network in Orphan Cardiovascular Diseases. EU Project inauguration

Both international and Polish cardiology community warmly welcomed our prior international project entitled Establishing a European Network for Orphan Cardiovascular Diseases (European Regional Development Fund and Małop...

The atrial septal defect diagnosed in the senility – the benefit of the transcatheter closure (RCD code: IV‑2B.1)

Objective: Closure of the atrial septal defect in the elderly patients is controversial. The aim of the study was to evaluate the outcomes of transcatheter closure of secundum atrial septal defect (ASD) in elderly patien...

Download PDF file
  • EP ID EP248122
  • DOI 10.20418/jrcd.vol1no5.130
  • Views 117
  • Downloads 0

How To Cite

Leszek Wrotniak, Anna kabłak-Ziembicka, Tadeusz Przewłocki, Piotr Pieniążek, Jakub Podolec, Krzysztof Żmudka (2013). Long‑term experience in patients undergoing endovascular revascularization procedures for symptomatic Takayasu arteritis (RCD code: I-3A.1). Journal of Rare Cardiovascular Diseases, 1(5), 8-13. https://europub.co.uk/articles/-A-248122